Patents by Inventor Samina Khan

Samina Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250078672
    Abstract: A reinforcement learning (RL) method for educational course selection includes the following steps: a) an action space and a state space are established, where actions of the action space represent actions associated with educational material and states of the state space represent learning states associated with a student; b) an action is selected from the action space; c) a next state is calculated based on the selected action and a current state; d) a reward is generated based on the current state and the next state; e) a Q-value is updated in a corresponding position in a Q-value table based on the reward; and f) the state is updated and the process returns to step b) when a final state is not reached, and an optimized action is output to the student when the final state is reached. The optimized action represents an educational course recommendation.
    Type: Application
    Filed: September 5, 2023
    Publication date: March 6, 2025
    Inventors: THEYAZN HASSN HADI ALDHYANI, MOSLEH HMOUD AL-ADHAILEH, M. IRFAN UDDIN, SAMINA AMIN, WALI KHAN MASHWANI
  • Publication number: 20140121164
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 1, 2014
    Inventors: SOREN NIELSEN, THOMAS ENGELBRECHT NORDKILD JONASSEN, SAMINA KHAN, MARK T. HOUSER, IB BO LUMHOLTZ, MICHAEL BECKERT, THOMAS BEAVER
  • Publication number: 20140100162
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: June 20, 2013
    Publication date: April 10, 2014
    Applicant: AbbVie, Inc.
    Inventors: Soren Nielsen, Thomas Engelbrecht Nordkild Jonassen, Samina Khan, Mark T. Houser, Ib Bo Lumholtz, Michael Beckert, Thomas Beaver
  • Publication number: 20140100165
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: March 15, 2013
    Publication date: April 10, 2014
    Inventors: Soren Nielsen, Thomas Engelbrecht Nordkilk Jonassen, Samina Khan, Mark T. Houser, Ib Bo Lumholtz, Michael Beckert, Thomas Beaver